17th May 2018: Aberdeen, Scotland: Elasmogen Ltd, developer of soloMERTM biologics, today announced that Dr Caroline Barelle was named as the winner in the “Rising Stars: Extraordinary Talent (2017)” category at last night’s Scotland’s Life Sciences Dinner & Annual Awards, held at the Hilton hotel Glasgow and attended by over 700 of Scotland’s top Life Sciences industry leaders.
Dr Barelle founded Elasmogen Ltd in 2016 and has rapidly established the company as a global biotech with an international profile and late-stage, pre-clinical products positioned to make a “sight-saving” difference in ophthalmology. This award also recognises Dr Barelle’s success at securing collaborative partnerships with companies that include Almac Discovery Ltd and the US bio-pharmaceutical giant, Amgen Inc.
Dr Caroline Barelle, CEO of Elasmogen Ltd, said: “To be acknowledged in this way by my life science industry peers is a fantastic honour and recognition of how far we have come and how quickly. I would like to thank all Elasmogen’s team, our stakeholders and funders for their support. Without their collective commitment and efforts over the past 2 years, this award would not have been possible.”
For additional information on Elasmogen’s technology and pipeline of soloMER biologics please visit www.elasmogen.com.